Cetuximab Biosimilar - GAALIE Research Grade

Human

EGFR

5mg/ml

Human IgG1 (Mutation)-kappa

CHO Cells

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects human EGFR.

Blue ice

A key oncogenic driver in many epithelial cancers, the epidermal growth factor receptor (EGFR) is among the most heavily investigated targets in cancer biology. This GAALIE-engineered, research-grade anti-human EGFR recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of cetuximab, with an Fc variant tuned for altered receptor engagement and intended for research use only. Validated for functional assays and produced to in vivo standards as an ultra-pure, low-endotoxin preparation, it is supplied in scalable milligram to gram quantities for high-throughput and bulk laboratories. It supports preclinical work including EGFR-blocking studies, effector-function assays, in vivo tumour models, and biologics and ADC development.

Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, ERBB, ERBB1, HER1

P00533

ICH3001-100ml ICH3002-100ml ICH3003-100ml

https://www.imgt.org/mAb-DB/